Skip to content
10-Q

Quarterly Report

PRELUDE THERAPEUTICS INC PRLD

0001193125-25-275887

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 62.87M sh
Shares Diluted Q3 2025 · Sep 30, 2025 76.13M sh
Shares Diluted Q3 2025 · Sep 30, 2025 76.04M sh
Shares Diluted Q3 2025 · Sep 30, 2024 75.86M sh
Shares Diluted Q3 2025 · Sep 30, 2024 75.78M sh
Capex Q3 2025 · Sep 30, 2025 $67K
Capex Q3 2025 · Sep 30, 2024 $711K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$79.42M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$82.14M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $47.53M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $12.47M
Stockholders Equity Q3 2025 · Sep 30, 2025 $58.53M
Stockholders Equity Q3 2025 · Jun 30, 2025 $75.84M
Stockholders Equity Q3 2025 · Mar 31, 2025 $103.18M
Stockholders Equity Q3 2025 · Dec 31, 2024 $131.46M
Stockholders Equity Q3 2025 · Sep 30, 2024 $156.43M
Stockholders Equity Q3 2025 · Jun 30, 2024 $182.28M
Stockholders Equity Q3 2025 · Mar 31, 2024 $210.73M
Stockholders Equity Q3 2025 · Dec 31, 2023 $237.09M
Current Liabilities Q3 2025 · Sep 30, 2025 $18.19M
Current Liabilities Q3 2025 · Dec 31, 2024 $25.64M
Total Liabilities Q3 2025 · Sep 30, 2025 $36.22M
Total Liabilities Q3 2025 · Dec 31, 2024 $44.06M
Current Assets Q3 2025 · Sep 30, 2025 $58.33M
Current Assets Q3 2025 · Dec 31, 2024 $135.9M
Total Assets Q3 2025 · Sep 30, 2025 $94.76M
Total Assets Q3 2025 · Dec 31, 2024 $175.52M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.26
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.09
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.43
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.30
Eps Basic Q3 2025 · Sep 30, 2025 −$0.26
Eps Basic Q3 2025 · Sep 30, 2025 −$1.09
Eps Basic Q3 2025 · Sep 30, 2024 −$0.43
Eps Basic Q3 2025 · Sep 30, 2024 −$1.30
Sga Expense Q3 2025 · Sep 30, 2025 $5.21M
Sga Expense Q3 2025 · Sep 30, 2025 $17.41M
Sga Expense Q3 2025 · Sep 30, 2024 $7.92M
Sga Expense Q3 2025 · Sep 30, 2024 $22.51M
Rd Expense Q3 2025 · Sep 30, 2025 $21.71M
Rd Expense Q3 2025 · Sep 30, 2025 $76.31M
Rd Expense Q3 2025 · Sep 30, 2024 $29.46M
Rd Expense Q3 2025 · Sep 30, 2024 $86.38M
Net Income Q3 2025 · Sep 30, 2025 −$19.73M
Net Income Q3 2025 · Sep 30, 2025 −$83.04M
Net Income Q3 2025 · Jun 30, 2025 −$31.23M
Net Income Q3 2025 · Mar 31, 2025 −$32.09M
Net Income Q3 2025 · Sep 30, 2024 −$32.27M
Net Income Q3 2025 · Sep 30, 2024 −$98.44M
Net Income Q3 2025 · Jun 30, 2024 −$34.74M
Net Income Q3 2025 · Mar 31, 2024 −$31.43M
Operating Income Q3 2025 · Sep 30, 2025 −$20.42M
Operating Income Q3 2025 · Sep 30, 2025 −$87.22M
Operating Income Q3 2025 · Sep 30, 2024 −$34.38M
Operating Income Q3 2025 · Sep 30, 2024 −$105.88M
Revenue Q3 2025 · Sep 30, 2025 $6.5M
Revenue Q3 2025 · Sep 30, 2025 $6.5M
Revenue Q3 2025 · Sep 30, 2024 $3M
Revenue Q3 2025 · Sep 30, 2024 $3M